Kliniko-geneticheskaya geterogennost' pervichnoy giperoksalurii 1-go tipa


Cite item

Full Text

Abstract

Clinical evolution, prognosis and treatment options of primary hyperoxaluria with case report description are discussed.

References

  1. Игнатова М.С., Вельтищев Ю.Е. Детская нефрология. Руководство для врачей. Л.: Медицина. 1989.
  2. Coward R, Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child 2003; 88: 962-965
  3. . 3. Danpure CJ, Jennings PR. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. Clinical Science 1986; 70 (5):417-425.
  4. Purdue PE, Lumb MJ, Fox M. et al. Characterisation and chromosomal mapping of a genomic clone encoding human alanine glyoxylate aminotransferase. Genomics 1991; 10: 34-42.
  5. Hoppe B, Langman C. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986-91.
  6. Mistry J DC, Chalmers RA. Hepatic D-glycerate dehydrogenase and glyoxylate reductase deficiency in primary hyperoxaluria type 2. Biochemical Society Transactions 1988; 16: 626.
  7. Rumsby G, Cregeen DP. Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase. Biochem Biophys Acta 1999; 1446: 383-388.
  8. Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 1999; 8: 2063-2069.
  9. Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C. et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 2010; 87(3): 392-9.
  10. Cochat P, Deloraine A, Rolity M, Olive F, Liponski I, Deries N. Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant 1995; 10 (8): 3 - 7.
  11. Kopp N, Leumann E. Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 1995; 10(12): 2224-7.
  12. Van Woerden CS, Jaap W, Groothoff F. et al. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004; 66: 746-750.
  13. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Annual report 2010. The EMMES Corporation, Rockville, MD.
  14. Lewis M, Shaw J, Reid C, Evans J, Webb N, Verrier-Jones K. Demography and management of childhood established renal failure in the UK. Nephrol Dial Transplant 2007; 22 (7): 65-75.
  15. Hattori S, Yosioka K, Honda M, Ito H. Japanese Society for Pediatric Nephrology. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 2002; 17(6): 456-61.
  16. Oxalosis and Hyperoxaluria Foundation, 2009, www.ohf.org <http://www.ohf.org>.
  17. Cochat P, Koch Nogueira PC, Mahmoud AM, Jamieson NV, Scheinman JI, Rolland MO. Primary hyperoxaluria in infants: medical, ethical and economic issues. J Pediatr 1999; 135: 746-750.
  18. Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL. et al. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 2003; 76: 1458-1463.
  19. Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A. et al. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 2010; 77(5): 443-9.
  20. Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL. et al. International registry for primary hyperoxaluria. Am J Nephrol 2005; 25: 290-6.
  21. Toussaint C, Vienne A, De Pauw L, Gelin M, Janssen F, Hall M. et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Bone histopathology and oxalate body content. Transplantation 1995; 59(12): 1700-4.
  22. Day DL, Scheinman JI, Mahan J. Radiological aspects of primary hyperoxaluria. Am J Roentgenol 1986; 146(2): 395-401.
  23. Leumann EP, Dietl A, Matasovic A. Urinary oxalate and glycolate excretion in healthy infants and children. Pediatr Nephrol 1990; 4(5): 493-7.
  24. Hoppe B, Leumann E, Milliner D. Urolithiasis in childhood. In: Geary D, Schafer F (eds). Comprehensive Pediatric Nephrology. Elsevier/WB Saunders: New York, 2008; 499-52.
  25. Danpure CJ. Primary hyperoxaluria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8 ed. Том 2. New York: McGraw-Hill; 2001. 3323-67.
  26. Daudon M, Jungers P. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Nephron Physiol 2004; 98: 31-6.
  27. Wong PN, Law ELK, Tong GMW, Mak SK, Lo KY, Wong AKM. Diagnosis of primary hyperoxaluria type 1 by determination of peritoneal dialysate glycolic acid using standard organic-acids analysis method. Perit Dial Int 2003; 23: 210-3.
  28. Takada Y, Kaneko N, Esumi H, Purdue PE, Danpure CJ. Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon. Biochem. J. 268 (1990); 517-520.
  29. Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, Monico CG. et al. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat 2009; 30: 910-917.
  30. Niaudet P. Primary hyperoxaluria. Orphanet encyclopedia. March 2004, www.orpha.net/data/patho/GB/uk-oxalos.pdf.
  31. Small KW, Scheinman J, Klintworth GK. A clinicopathological study of ocular involvement in primary hyperoxaluria. N Engl J Med 1994; 331: 1553.
  32. Frishberg Y, Rinat C, Shalata A. et al. Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol 2005; 25: 269-275.
  33. Hoppe B, Danpure CJ, Rumsby G et al. A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: lack of relationship between genotype, enzymatic phenotype and disease severity. Am J Kidney Dis 1997; 29: 36-44.
  34. Danpure CJ. Primary hyperoxaluria: from gene defects to designer drugs? Nephrol Dial Transplant 2005; 20: 1525-9.
  35. Monico CG, Rosetti S, Olson JB, Milliner DS. Pyridoxine effect in type 1 primary hyperoxaluria is associated with the commonest mutant allele. Kidney Int 2005; 67: 1704-1709.
  36. Santana A, Salido E, Torres A, Shapiro LJ. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase. Proc Natl Acad Sci USA 2003; 100(12): 7277-82.
  37. Beck B, Hoppe B. Is there a genotype-phenotype correlation in primary hyperoxaluria type 1? Kidney International 2006; 70: 984-986.
  38. Borghi L, Meschi T, Amato F. et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996; 155: 839-43.
  39. Monico CG, Rossetti S, Olson JB. et al. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 2005; 67: 1704-9.
  40. Leumann E, Hoppe B, Neuhaus T. Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol 1993; 7: 207-11.
  41. Hoppe B, Beck B, Gatter N. et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 2006; 70: 1305-11.
  42. Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int 2006; 70: 1642-8.
  43. Diaz C, Catalinas FG, de Alvaro F, Torre A, Sanchez C, Costero O. Long daily hemodialysis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report. Ther Apher Dial 2004; 8(1): 52-5.
  44. Van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003; 18(2): 273-9.
  45. Cochat P, Fargue S, Harambat J. Primary hyperoxaluria type 1: strategy for organ transplantation. Curr Opin Organ Transplant 2010; 15(5): 590-3.
  46. Malla I, Lysy PA, Godefroid N. et al. Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation. Pediatr Transplant 2009; 13: 82-4.
  47. Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G & Wing AJ. Kidney transplantation in primary oxalosis: Data from the EDTA registry. Nephrol Dial Transplant 1990; 5: 332−336.
  48. Lumb MJ, Danpure CJ. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem 2000; 275: 36415 -36422.
  49. Galanti M, Contreras A. Excellent renal function and reversal of nephrocalcinosis 8 years after isolated liver transplantation in an infant with primary hyperoxaluria type 1. Pediatr Nephrol 2010; 25: 2359-2362.
  50. Purdue PE, Lumb MJ, Fox M, Griffo G, Hamon-Benais C, Povey S, Danpure CJ. Characterization and chromosomal mapping of a genomic clone encoding human alanine-glyoxylate aminotransferase. Genomics 1991; 10: 34 -42.
  51. Coulter-Mackie MB, Rumsby G. Genetic heterogeneity in primary hyperoxaluria type 1: Impact on diagnosis. Mol Genet Metab 2004; 83: 38 -46.
  52. Flye MW, Duffy B, Phelan D, Ratner LE, Mohanakumar T. Protective effects of liver transplantation on a simultaneous transplanted kidney in a highly sensitized patient. Transplantation 1990; 50: 1051−1054.
  53. Parekh RS, Smoyer WE, Bunchman TE. Diagnosis and management of primary hyperoxaluria type 1 in infancy. Pediatr Transplant 1997; 1: 48-54.
  54. Gagnadoux M F, Niaudet P. Long-term results of combined liver-kidney transplantation in six children with primary hyperoxaluria. Nephrol Dial Transplant (workshop abstract) 1999; 14: 2784-9.
  55. Zhang X, Roe SM, Hou Y, Bartlam M, Rao Z, Pearl LH. et al. Crystal structure of alanine-glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. J Mol Biol 2003; 331: 643-652.
  56. Danpure CJ, Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Biochimica et Biophysica Acta 1763 2006; 1776-1784. 57. Quispe Gonzales JO et al., Delayed diagnosis of primary hyperoxaluria in a young patient with advanced chronic renal failure. Nefrologia 2011; 31(2):227-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies